Furthermore, SIRT1 is an important marker of poor prognosis [12]; SIRT1 is associated with poor clinicopathological manifestations, including tumor size, lymph node metastasis, and advanced tumor invasion [14]. This evidence concerns the gene SIRT1 and neoplasm.